BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35413740)

  • 1. FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance.
    Szczepańska E; Gietka-Czernel M
    Horm Metab Res; 2022 Apr; 54(4):203-211. PubMed ID: 35413740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
    Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
    Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.
    Stöhr O; Tao R; Miao J; Copps KD; White MF
    Cell Rep; 2021 Mar; 34(12):108893. PubMed ID: 33761350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parsing the Potential Neuroendocrine Actions of FGF21 in Primates.
    Gillum MP
    Endocrinology; 2018 May; 159(5):1966-1970. PubMed ID: 29608670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism.
    Caixeta LS; Giesy SL; Krumm CS; Perfield JW; Butterfield A; Boisclair YR
    J Dairy Sci; 2019 Dec; 102(12):11597-11608. PubMed ID: 31548064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.
    Camporez JP; Jornayvaz FR; Petersen MC; Pesta D; Guigni BA; Serr J; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Shulman GI
    Endocrinology; 2013 Sep; 154(9):3099-109. PubMed ID: 23766126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.
    Markan KR; Naber MC; Ameka MK; Anderegg MD; Mangelsdorf DJ; Kliewer SA; Mohammadi M; Potthoff MJ
    Diabetes; 2014 Dec; 63(12):4057-63. PubMed ID: 25008183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
    Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
    Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
    Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
    J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
    Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
    Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
    Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
    Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.